VCP
MDT icon

Verus Capital Partners’s Medtronic MDT Stock Holding History

Verus Capital Partners’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,340
Closed -$208K – 301
2022
Q2 		$208K Sell
2,340
-58
-2% -$5.88K 0.04% 268
2022
Q1 		$248K Buy
+2,398
New +$253K 0.04% 266
2020
Q1 		$261K Sell
2,897
-2,555
-47% -$272K 0.08% 150
2019
Q4 		$618K Buy
+5,452
New +$598K 0.2% 83

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Verus Capital Partners's MDT Position: Q3 2022 in Review

Verus Capital Partners sold out of Medtronic (MDT) in Q3 2022, closing a stake of 2,340 shares — an estimated $208K sold.

Verus Capital Partners first reported a position in MDT in Q4 2019 and held it in 4 quarters. The position peaked at $618K in Q4 2019. 1,931 funds tracked by Wall St. Rank hold MDT as of Q3 2022.

  • Verus Capital Partners reported no remaining Medtronic position as of Q3 2022 after selling out during the quarter.
  • Verus Capital Partners sold 2,340 Medtronic shares in Q3 2022, an estimated $208K.
  • Verus Capital Partners first reported a position in Medtronic in Q4 2019 and held it in 4 quarters.
  • Verus Capital Partners's Medtronic position peaked at $618K in Q4 2019.
  • 1,931 funds tracked by Wall St. Rank held Medtronic as of Q3 2022.

Based on Verus Capital Partners's 13F filing for Q3 2022, filed 15 Nov 2022.